1. miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
- Author
-
Yeting Hong, Jiangning Chen, Mengchao Yu, Junfeng Zhang, Chihao Zhao, Hongwei Liang, Yu Guo, Kai Yin, Xinyan Zhou, Yanqing Liu, Xi Chen, Rongjie Cheng, Uzair-ur-Rehman, Chen-Yu Zhang, Minghui Liu, Fei Yang, and Feng Zhi
- Subjects
0301 basic medicine ,Male ,Programmed cell death ,Colorectal cancer ,miR-181b ,lcsh:Animal biochemistry ,Mice, Nude ,colorectal cancer ,Mice, SCID ,Biology ,medicine.disease_cause ,Bioinformatics ,Biochemistry ,Stat3 Signaling Pathway ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Downregulation and upregulation ,Drug Discovery ,microRNA ,medicine ,Animals ,Humans ,RNA, Neoplasm ,lcsh:QH573-671 ,lcsh:QP501-801 ,Cell Proliferation ,PDCD4 ,lcsh:Cytology ,Cancer ,RNA-Binding Proteins ,Cell Biology ,Oncomir ,medicine.disease ,Neoplasm Proteins ,MicroRNAs ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,Heterografts ,Caco-2 Cells ,Carcinogenesis ,Apoptosis Regulatory Proteins ,Colorectal Neoplasms ,Neoplasm Transplantation ,Biotechnology ,Research Article - Abstract
Programmed cell death 4 (PDCD4) is a RNA-binding protein that acts as a tumor suppressor in many cancer types, including colorectal cancer (CRC). During CRC carcinogenesis, PDCD4 protein levels remarkably decrease, but the underlying molecular mechanism for decreased PDCD4 expression is not fully understood. In this study, we performed bioinformatics analysis to identify miRNAs that potentially target PDCD4. We demonstrated miR-181b as a direct regulator of PDCD4. We further showed that activation of IL6/STAT3 signaling pathway increased miR-181b expression and consequently resulted in downregulation of PDCD4 in CRC cells. In addition, we investigated the biological effects of PDCD4 inhibition by miR-181b both in vitro and in vivo and found that miR-181b could promote cell proliferation and migration and suppress apoptosis in CRC cells and accelerate tumor growth in xenograft mice, potentially through targeting PDCD4. Taken together, this study highlights an oncomiR role for miR-181b in regulating PDCD4 in CRC and suggests that miR-181b may be a novel molecular therapeutic target for CRC. Electronic supplementary material The online version of this article (doi:10.1007/s13238-016-0313-2) contains supplementary material, which is available to authorized users.
- Published
- 2016
- Full Text
- View/download PDF